| __timestamp | Novavax, Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 79435000 | 242549000 |
| Thursday, January 1, 2015 | 162644000 | 245098000 |
| Friday, January 1, 2016 | 237939000 | 147600000 |
| Sunday, January 1, 2017 | 168435000 | 264600000 |
| Monday, January 1, 2018 | 173797000 | 357900000 |
| Tuesday, January 1, 2019 | 113842000 | 1182600000 |
| Wednesday, January 1, 2020 | 747027000 | 357700000 |
| Friday, January 1, 2021 | 2534508000 | 540100000 |
| Saturday, January 1, 2022 | 1235278000 | 322900000 |
| Sunday, January 1, 2023 | 737502000 | 408000000 |
Unleashing the power of data
In the ever-evolving world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, United Therapeutics Corporation and Novavax, Inc. have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Novavax's R&D expenses surged by over 900%, peaking in 2021 with a remarkable 2.5 billion dollars, driven by their pivotal role in vaccine development. In contrast, United Therapeutics maintained a more consistent R&D trajectory, with a notable spike in 2019, reaching approximately 1.2 billion dollars. This divergence highlights Novavax's aggressive push in response to global health challenges, while United Therapeutics focused on steady, long-term innovation. As the biotech landscape continues to shift, these spending patterns offer a glimpse into the strategic priorities of these industry leaders.
Research and Development Expenses Breakdown: Novo Nordisk A/S vs Novavax, Inc.
R&D Insights: How Pfizer Inc. and Novavax, Inc. Allocate Funds
United Therapeutics Corporation or Sarepta Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: United Therapeutics Corporation vs Halozyme Therapeutics, Inc.
United Therapeutics Corporation or Grifols, S.A.: Who Invests More in Innovation?
Comparing Innovation Spending: United Therapeutics Corporation and Ultragenyx Pharmaceutical Inc.
Research and Development Investment: United Therapeutics Corporation vs Corcept Therapeutics Incorporated
R&D Spending Showdown: United Therapeutics Corporation vs Alkermes plc
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and ImmunityBio, Inc.
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and Bausch Health Companies Inc.
Comparing Innovation Spending: Pharming Group N.V. and Novavax, Inc.
Analyzing R&D Budgets: Amphastar Pharmaceuticals, Inc. vs Novavax, Inc.